| Phrase | Consultant | Town | Special Interests |
| cardiology clinical trials | *Consultant(s)* | *Towns* | Coronary intervention, cardiology clinical trials, technology research, cardiac arrest medicine, coronary physiology |
| chemotherapy trials | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal tract cancer, chemotherapy trials, pancreatic cancer, CUP - carcinoma of unknown primary |
| clinical research in clinical trials - phase 1 | *Consultant(s)* | *Towns* | Medical oncology, melanoma, clinical research in clinical trials - phase 1, urological oncology |
| clinical trials | *Consultant(s)* | *Towns* | Epidemiology, lipidology, clinical trials |
| clinical trials | *Consultant(s)* | *Towns* | Medical oncology, clinical trials, cancer therapeutics, drug development |
| Clinical trials | *Consultant(s)* | *Towns* | Clinical trials, epidemiology, lipidology |
| clinical trials | *Consultant(s)* | *Towns* | Vascular surgery, clinical trials |
| clinical trials | *Consultant(s)* | *Towns* | Headache, MS - multiple sclerosis, Parkinson's disease, stroke, general neurology, clinical trials, dementia |
| clinical trials | *Consultant(s)* | *Towns* | Medical oncology, hepatobiliary cancer, pancreatic cancer, melanoma, clinical trials |
| clinical trials | *Consultant(s)* | *Towns* | Intensive care medicine, sepsis, clinical trials, precision medicine |
| clinical trials | *Consultant(s)* | *Towns* | CKD - chronic kidney disease, clinical trials |
| clinical trials | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, clinical trials, experimental therapies |
| clinical trials | *Consultant(s)* | *Towns* | Hypertension, clinical trials, phaeochromocytoma |
| clinical trials | *Consultant(s)* | *Towns* | Chronic genito-urinary problems, clinical trials, HIV prevention trials |
| clinical trials | *Consultant(s)* | *Towns* | Medical oncology, gynaecological cancer, clinical trials |
| clinical trials | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancers, clinical trials, pancreatic neuroendocrine tumours, hepatobiliary cancers |
| clinical trials | *Consultant(s)* | *Towns* | Medical oncology, teenage and young adult oncology, sarcoma, breast cancer, germ cell tumours, clinical trials |
| clinical trials (various including experimental medicine trials) | *Consultant(s)* | *Towns* | Psoriatic arthritis, axSpA/ankylosing spondylitis, rheumatoid arthritis, spondyloarthropathy, COVID-19 in rheumatic patients, clinical trials (various including experimental medicine trials), biomarkers for rheumatic diseases |
| Clinical trials and health service research | *Consultant(s)* | *Towns* | Clinical trials and health service research, rheumatoid arthritis |
| clinical trials in liver disease | *Consultant(s)* | *Towns* | Sepsis in liver disease, nutrition in liver disease, cirrhosis, clinical trials in liver disease, abnormal liver blood tests, fibroscan |
| clinical trials in lower gastrointestinal cancer | *Consultant(s)* | *Towns* | Clinical oncology, upper and lower gastrointestinal cancer, clinical trials in lower gastrointestinal cancer, advanced thyroid cancer |
| clinical trials of new agents | *Consultant(s)* | *Towns* | Non surgical treatment of prostate cancer, prostate iodine seed brachytherapy, image-guided intensity modulated external beam radiotherapy for prostate cancer, chemotherapy and systemic therapy for prostate cancer, bladder cancer chemotherapy and radiotherapy, clinical trials of new agents, prostate stereotactic body radiotherapy, focal salvage seed brachytherapy |
| core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
| design and set up of clinical trials | *Consultant(s)* | *Towns* | Diagnostic and interventional neuroradiology, design and set up of clinical trials, device development and evaluation (CE-marking), high-fidelity medical simulation, reference site (core laboratory for clinical trials), set up of thrombectomy services |
| development of early phase clinical trials of anti-cancer therapies | *Consultant(s)* | *Towns* | Medical oncology, development of early phase clinical trials of anti-cancer therapies |
| Drug trials | *Consultant(s)* | *Towns* | Drug trials |
| drug trials | *Consultant(s)* | *Towns* | Digital mental health, drug trials |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, pancreatic cancer, gastrointestinal cancer, neuroendocrine tumours, early phase clinical trials |
| early phase clinical trials | *Consultant(s)* | *Towns* | Paediatric neuro-oncology, neuroblastoma, early phase clinical trials |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal cancer, endocrine cancer, hepatobiliary tumours, early phase clinical trials |
| Early phase clinical trials | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, early phase clinical trials, immunotherapy |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, metastatic melanoma, early phase clinical trials |
| early phase trials | *Consultant(s)* | *Towns* | Medical oncology, thoracic oncology, lung cancer, early phase trials |
| early phase trials for childhood leukaemia | *Consultant(s)* | *Towns* | Paediatric oncology, childhood leukaemia and lymphoma, early phase trials for childhood leukaemia |
| haematological clinical trials | *Consultant(s)* | *Towns* | Chronic lymphocytic leukaemia, haematological clinical trials, teenage and young adult cancer |
| HIV prevention trials | *Consultant(s)* | *Towns* | Chronic genito-urinary problems, clinical trials, HIV prevention trials |
| phase 1 - 2 trials | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, cancer drug development, phase 1 - 2 trials |
| phase 1 trials | *Consultant(s)* | *Towns* | Medical oncology, melanoma, liver cancer, inoperable cancer, phase 1 trials, upper gastrointestinal cancers |
| Pragmatic clinical trials | *Consultant(s)* | *Towns* | Pragmatic clinical trials, research lifecycle |
| randomised stents trials | *Consultant(s)* | *Towns* | Coronary angiography, percutaneous coronary intervention, randomised stents trials, clinical cardiology |
| reference site (core laboratory for clinical trials) | *Consultant(s)* | *Towns* | Diagnostic and interventional neuroradiology, design and set up of clinical trials, device development and evaluation (CE-marking), high-fidelity medical simulation, reference site (core laboratory for clinical trials), set up of thrombectomy services |
| research and clinical trials | *Consultant(s)* | *Towns* | Acute coronary syndromes, heart failure, arrhythmia, hypertension, metabolic syndrome, health economics, research and clinical trials, medical statistics, cardiology guidelines, cardiovascular epidemiology, valve disease, device therapy, audit and national policy, atypical chest pain, cardiac risk reduction |
| research trials | *Consultant(s)* | *Towns* | Oncoplastic breast surgery, reconstructive breast surgery, benign breast conditions, breast cancer, medical education, research trials |
| vaccine clinical trials | *Consultant(s)* | *Towns* | Meningitis/sepsis/meningococcal disease, vaccine clinical trials |
